On March 4, 2024, analyst Emily Bodnar from HC Wainwright & Co. initiated coverage on Connect Biopharma Holdings Ltd (NASDAQ:
Analyst Initiates Coverage on Connect Biopharma Holdings Ltd with Buy Rating and 7 Price Target
Mar 4, 2024